Navigation Links
New OTC Allergy Treatment Available to Food Allergy Sufferers
Date:3/26/2009

Allertherapy(TM) Makes Allergy Desensitization an Accessible and Cost-Effective Option

FORT COLLINS, Colo., March 26 /PRNewswire/ -- Food allergy sufferers now have a treatment option that builds immunity to food allergens from the comfort of home. Allertherapy(TM) is a natural treatment that gently builds tolerance to targeted foods. The Allertherapy(TM) method is similar in concept to allergy shots. It quickly builds immunity to allergens and maintains it over time. The easy-to-use oral spray uses a low, homeopathic allergen strength of one part per million to allow for safety of use in most allergy sufferers. The food mix contains many of the most common allergy-causing foods. Users can quickly build immunity and reduce targeted allergies. Hence, the treatment may help to reduce allergic reactions and dependence on medications.

Much attention has been given to the findings by researchers from Duke University Medical Center and Arkansas Children's Hospital. Their studies found that five of nine children with serious peanut allergies, and under doctor supervision, were able to quickly build a tolerance to peanuts. The study used doses as low as 1/1000th of a peanut, and increased up to 15 peanuts a day over a ten-month period. Four of the nine children could not tolerate the treatment and dropped out. This study showed great promise for new food allergy treatments, such as Allertherapy(TM).

Low-concentration homeopathic medications are based on the theory of "like cures like." For example, a dairy allergy can be treated with a homeopathic concentration of dairy. Traditional immunotherapy, or allergy shots, also uses this theory. Allertherapy(TM) is a natural treatment that uses a significantly lower concentration than used in traditional immunotherapy, making it a gentler and safer choice for most allergy sufferers. Additionally, in the studies as well as in traditional immunotherapy, the concentration was increased over time. Many of the adverse reactions that occur during traditional immunotherapy occur when the concentration is increased. Allertherapy(TM) maintains a constant dose and concentration, which decreases the potential for bad reactions, yet allows for desensitization to occur. The sublingual application permits rapid absorption, and reduces abdominal discomfort that might otherwise accompany it in some users.

Many mild to moderate allergy sufferers do not qualify for allergy shots or trials. For those that desire to directly treat the allergy rather than merely mask allergy symptoms, Allertherapy(TM) offers a new, natural choice. Because Allertherapy(TM) contains allergens, it is important to note that those with severe allergies must only use this treatment with doctor approval and under doctor supervision, should a severe reaction occur.

Allertherapy(TM) is cost-effective -- and timely in today's economy. Many with mild allergies can use Allertherapy(TM) without doctor supervision. Because it is a natural treatment, it is available over-the-counter; no prescription is required. Since Allertherapy(TM) can reduce or eliminate targeted allergies, future healthcare costs can be reduced or eliminated. Over time, the savings can be significant.

For more information, visit http://www.allertherapy.com.

    Contact:

    Connie Williams
    ProActive Remedies, LLC
    information@proactiveremedies.com
    800-874-0989 ext.300

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE ProActive Remedies, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Clinical Study News for Treatment of Sinusitis, Sinus Infection and Allergy Sufferers Now Have a New Effective Form of Relief through Sinus Dynamics
2. New Clinical Study News for Treatment of Sinusitis - Sinus Infection and Allergy Suffers Now Have a New Effective Form of Relief through Sinus Dynamics
3. Food Allergy Initiative to Partner With NYC Department of Health on Educational Poster for Restaurants Citywide
4. Irelands Allergy Standards Limited Adds Two New U.S. Names to Line-Up of Companies Making Allergy-Certified Consumer Products
5. Food Allergy Labeling Not Always Accurate
6. Exposure to Peanuts May Build Tolerance to Allergy
7. Global Warming Expected to Spike Pollen and Spring Allergies - New Drug-Free Topical Gels Boost Hope for Allergy Sufferers
8. Take Action, Prevent Reactions at FAANs Annual Food Allergy Conferences
9. Coming Clean: New Allergy Specialty Store is Land of Plenty for All People With Allergies
10. Precautionary Allergy Alert on Undeclared Milk Protein in Expired Codes of Broughton Foods Pints of Orange Juice, Citrus Punch, Fruit Punch and Iced Tea Products
11. Herbal Remedy Could Halt Peanut Allergy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 17, 2017 , ... Focused ... innovation in the industry, according to the recent NEJM Catalyst Insights Report on ... of the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical ...
(Date:2/18/2017)... ... 2017 , ... A new directory from the Senior Veterans ... connect elderly veterans of America's armed forces to a range of senior care ... on this year's increase in the Veterans Pension with Aid & Attendance for ...
(Date:2/17/2017)... ... 2017 , ... For the first time, International Scholarship and ... floor for the 2017 HIMSS Conference & Exhibition at the Orange ... than 40,000 healthcare industry professionals are expected at the conference, where they will ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today ... Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will ... used electronic patient signatures solution in healthcare . , Since it first ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer diagnostics workflow solution provider ... 20 – 22 in San Francisco. As part of the Tri-Conference expo, which ... workflow solution, as well as its new precision medicine platform, “Crosswalk Insight: Oncology™.” ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for ... Vincent J. Angotti has been appointed ... company,s board of directors, effective Monday, March 6, ... experience leading executive and commercial teams at public ...
(Date:2/16/2017)... , Feb. 16, 2017  Prescription pain medications ... department visit are necessary for long-term opioid use to ... Feb. 16 th edition of The New ... "Emergency physicians see more patients in acute pain than ... Parker , MD, FACEP, president of the American College ...
(Date:2/16/2017)... Research and Markets has announced the addition of the ... Function, Application, Cancer Type, Technology - Forecast to 2025" report ... ... grow at a CAGR of around 28.6% over the next decade ... Some of the prominent trends that the market is witnessing include ...
Breaking Medicine Technology: